Breast Cancer
Reports summarize breast cancer study results from Boston University
Published in Oncology Business Week, November 1st, 2009
"Some medications compromise CYP2D6 activity and may lower plasma concentrations of active tamoxifen metabolites. We studied the association between concurrent use of tamoxifen and CYP2D6-inhibiting medications and breast cancer recurrence among Danish women diagnosed with early-stage, estrogen receptor-positive breast cancer. Using the Danish Breast Cancer Cooperative Group Registry, we identified 366 cases with local or...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Oncology Business Week
More Articles from Oncology Business Week
- Access to Integrated Cancer Care AICC
Congressional Letter Highlights Increased Racial Health Disparities and Barriers to Cancer Care in Proposed CMS Policy - Advanced Life Sciences Holdings, Inc.
Advanced Life Sciences to Present at 8th Annual BIO Investor Forum - Advaxis, Inc.
Advaxis Added to Stonegate's Equity Research Universe - Advaxis, Inc.
Advaxis Chief Science Officer to Present Benefits of Using Live Listeria as a Vaccine - Affymetrix, Inc.
Affymetrix Announces Major Genotyping Project With Kaiser Permanente and the University of California at San Francisco for NIH-Funded Epidemiology Study - Aging
Kaiser Permanente, UCSF Awarded $25 Million From NIH to Build Groundbreaking Resource for Genetic Epidemiology Research - More from this issue of Oncology Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
